About
Todd B. Sisitsky has served as a director of IQVIA since October 2016 and is currently a member of the Nominating and Governance and Leadership Development and Compensation Committees. Prior to that, he served as a director of IMS Health from February 2010 until October 2016. Mr. Sisitsky is President and Co-Managing Partner of TPG Capital and President of TPG, Inc., a NASDAQ listed company. Prior to joining TPG in 2003, he worked in executive roles at Forstmann Little & Company and Oak Hill Capital Partners. Mr. Sisitsky currently serves on the boards of directors of Allogene Therapeutics, Inc. and Convey Health Solutions Holdings, Inc., which are both publicly traded companies. He previously served on the boards of Endo International plc and IASIS Healthcare LLC. Mr. Sisitsky also chairs the board of advisors at Dartmouth Medical School and is a member of the boards of directors at Ellodi Pharmaceuticals and Immucor Inc. He has an MBA from Stanford Graduate School of Business, where he was an Arjay Miller Scholar, and has a Bachelor of Arts degree from Dartmouth College, where he graduated summa cum laude.
Personal Details
Qualifications & Experience
Other directorships (state)
(only entities turnover at least $5m p/a)
| Company | Committee | Position | Date Appointed |
|---|---|---|---|
| Board | Member | 01/04/2003 | |
| Executive | Member | 01/04/2003 |
Working history
Committee/s
| Company | Committee | Role | Appointment Date | Resignation Date |
|---|---|---|---|---|
| IQVIA Holdings Inc | Board | Member | 01/10/2016 | |
| IQVIA Holdings Inc | Nominations & Governance | Member | 01/10/2016 | |
| IQVIA Holdings Inc | Other (specify) | Member | 01/10/2016 |